Status:

TERMINATED

Safety, Tolerability and PK of Ensovibep (MP0420 - a New Candidate With Potential for Treatment of COVID-19)

Lead Sponsor:

Molecular Partners AG

Conditions:

COVID-19

Eligibility:

All Genders

18-65 years

Phase:

PHASE1

Brief Summary

This study will investigate how ensovibep is distributed throughout the body, the safety and the tolerability of ensovibep in healthy volunteers

Eligibility Criteria

Inclusion

  • Healthy male or female subjects between ages of 18-65 years
  • Body mass index of 18.0-35.0 kg/m2
  • Non-smokers for at least 3 months
  • Deemed healthy on the basis of a clinical history, physical examination, ECG, vital signs, and laboratory tests of blood and urine
  • Agree to follow the contraception requirements of the trial
  • Able to give fully informed written consent.

Exclusion

  • Positive tests for hepatitis B \& C, HIV
  • Severe adverse reaction to any drug
  • Drug or alcohol abuse
  • Use of over-the-counter medication (with the exception of paracetamol \[acetaminophen\]) during the 7 days before the first dose of trial medication, or prescribed medication during the 28 days before first dose of trial medication
  • Any vaccination within 4 weeks before dose of trial medication
  • Participation in other clinical trials of unlicensed medicines within the previous 3 months
  • Loss of more than 400 mL blood within the previous 3 months
  • Vital signs outside the acceptable range
  • Clinically relevant abnormal findings at the screening assessment
  • Acute or chronic illness
  • Clinically relevant abnormal medical history or concurrent medical condition
  • Possibility that volunteer will not cooperate
  • Females who are pregnant or lactating, or who are sexually active and not using a reliable method of contraception.

Key Trial Info

Start Date :

November 18 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 6 2022

Estimated Enrollment :

53 Patients enrolled

Trial Details

Trial ID

NCT04870164

Start Date

November 18 2020

End Date

January 6 2022

Last Update

March 18 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

HMR

London, United Kingdom, NW10 7EW